PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.21%
Revenue growth 1.25-1.5x ADI's 8.83%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
21.35%
Gross profit growth above 1.5x ADI's 12.26%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
103.17%
EBIT growth below 50% of ADI's 1320.00%. Michael Burry would suspect deeper competitive or cost structure issues.
103.17%
Operating income growth under 50% of ADI's 1320.00%. Michael Burry would be concerned about deeper cost or sales issues.
80.00%
Net income growth under 50% of ADI's 490.00%. Michael Burry would suspect the firm is falling well behind a key competitor.
66.67%
EPS growth under 50% of ADI's 385.71%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
66.67%
Diluted EPS growth under 50% of ADI's 385.71%. Michael Burry would worry about an eroding competitive position or excessive dilution.
30.34%
Share count expansion well above ADI's 0.49%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
30.34%
Diluted share count expanding well above ADI's 0.49%. Michael Burry would fear significant dilution to existing owners' stakes.
-26.23%
Dividend reduction while ADI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
1562.50%
OCF growth above 1.5x ADI's 339.66%. David Dodd would confirm a clear edge in underlying cash generation.
163.89%
FCF growth above 1.5x ADI's 93.15%. David Dodd would verify if the firm’s strategic investments yield superior returns.
44.03%
10Y revenue/share CAGR at 75-90% of ADI's 54.54%. Bill Ackman would press for new markets or product lines to narrow the gap.
33.59%
5Y revenue/share CAGR at 75-90% of ADI's 41.09%. Bill Ackman would encourage strategies to match competitor’s pace.
17.30%
3Y revenue/share CAGR above 1.5x ADI's 11.36%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
461.80%
10Y net income/share CAGR of 461.80% while ADI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
43.62%
Net income/share CAGR of 43.62% while ADI is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
-30.51%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
90.48%
Dividend/share CAGR of 90.48% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
76.37%
Dividend/share CAGR of 76.37% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
76.37%
3Y dividend/share CAGR of 76.37% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
25.69%
Our AR growth while ADI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-2.17%
Inventory is declining while ADI stands at 2.56%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
7.24%
Asset growth above 1.5x ADI's 0.80%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-21.23%
We have a declining book value while ADI shows 0.64%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
19.09%
Debt growth far above ADI's 6.67%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
4.56%
SG&A growth well above ADI's 3.45%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.